Search

Author/Creator Bruzzone, B.

1. Analysis of resistance and phylogenetic clusters in HCV-2c infected patients within the Italian network Vironet C. (February 2020)

Authors:
Barbaliscia, S.; Di Maio, V.C.; Fabeni, L.; Teti, E.; Paolucci, S.; Minichini, C.; Aragri, M.; Rosa, K. Yu La; Carioti, L.; Pasquazzi, C.; Milana, M.; Foroghi, L.; Pollicino, T.; Licata, A.; Pieri, A.; Palitti, V. Pace; Bruzzone, B.; Micheli, V.; Bertoli, A.; Baiocchi, L.
Journal:
Digestive and liver disease
Issue:
Volume 52(2020)Supplement 1
Page Start:
e24
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance. (February 2019)

Authors:
Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Aragri, M.; Paolucci, S.; Masetti, C.; D'Ambrosio, R.; Degasperi, E.; Polilli, E.; Palitti, V. Pace; Fiorentino, G.; Foroghi, L.; Cento, V.; Scutari, R.; Bruzzone, B.; Calvaruso, V.; Coppola, N.; Gaeta, G.B.; Morsica, G.; Ghisetti, V.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Page Start:
e65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Characterization of resistance profiles in HCV 2-3-4 DAA-naïve and DAA-experienced infected patients in Italy. Issue 1 (February 2018)

Authors:
Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Lenci, I.; Aragri, M.; Polilli, E.; Fiorentino, G.; Pace Palitti, V.; Bruzzone, B.; Paolucci, S.; Coppola, N.; Ruggiero, T.; Pollicino, T.; Niero, F.; Micheli, V.; Nicolini, L.A.; Marenco, S.; Bertoli, A.; Maida, I.; Francioso, S.
Journal:
Digestive and liver disease
Issue:
Volume 50:Issue 1(2018)Supplement
Page Start:
46
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Factors associated with virological success with raltegravir‐containing regimens and prevalence of raltegravir‐resistance‐associated mutations at failure in the ARCA database1. (4th January 2013)

Authors:
Rusconi, S.; Vitiello, P.; Adorni, F.; Bruzzone, B.; De Luca, A.; Micheli, V.; Meraviglia, P.; Maserati, R.; Di Pietro, M.; Colao, G.; Penco, G.; Di Biagio, A.; Punzi, G.; Monno, L.; Zazzi, M.
Editors:
Antonelli, G.
Journal:
Clinical microbiology and infection
Issue:
Volume 19:Number 10(2013:Oct.)
Page Start:
936
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. (17th December 2015)

Authors:
Di Maio, V. C.; Cento, V.; Di Paolo, D.; Aragri, M.; De Leonardis, F.; Tontodonati, M.; Micheli, V.; Bellocchi, M. C.; Antonucci, F. P.; Bertoli, A.; Lenci, I.; Milana, M.; Gianserra, L.; Melis, M.; Di Biagio, A.; Sarrecchia, C.; Sarmati, L.; Landonio, S.; Francioso, S.; Lambiase, L.
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 71:Number 3(2016:Mar.)
Page Start:
739
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies. Issue 1 (16th February 2017)

Authors:
Di Maio, V.C.; Cento, V.; Lenci, I.; Aragri, M.; Barbaliscia, S.; Francioso, S.; Paolucci, S.; Melis, M.; Verucchi, G.; Masetti, C.; Coppola, N.; Magni, C.F.; Micheli, V.; Pollicino, T.; Ruggiero, T.; Landonio, S.; Mancon, A.; Starace, M.; De Leonardis, F.; Santopaolo, F.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. National quality control and validation of hepatitis C NS3, NS5A and NS5B genotypic resistance testing. Issue 1 (February 2018)

Authors:
Ruggiero, T.; Cento, V.; Aragri, M.; Arosio, M.; Baldanti, F.; Brunetto, M.; Bruzzone, B.; Boeri, E.; Cavallone, D.; Coppola, N.; Di Stefano, M.; Ghisetti, V.; Callegaro, A.P.; Capobianchi, M.R.; Caudai, C.; Cuomo, N.; Galli, S.; Galmozzi, E.; Garbuglia, A.R.; Gennari, W.
Journal:
Digestive and liver disease
Issue:
Volume 50:Issue 1(2018)Supplement
Page Start:
55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Natural HCV resistance is common in Italy and differently associated to genotypes. Issue 1 (16th February 2017)

Authors:
Sorbo, M.C.; Cento, V.; Bertoli, A.; Lenci, I.; Polilli, E.; Masetti, C.; Gianserra, L.; Teti, E.; Biliotti, E.; Magni, C.F.; Aragri, M.; Micheli, V.; Melis, M.; Nicolini, L.A.; Marenco, S.; Calvaruso, V.; Paolucci, S.; Baldanti, F.; Morisco, F.; Siciliano, M.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e52
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Prevalence and characteristics of resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy. Issue 1 (16th February 2017)

Authors:
Di Maio, V.C.; Barbaliscia, S.; Lenci, I.; Teti, E.; Antonucci, F.P.; Cento, V.; Aragri, M.; Paolucci, S.; Bruzzone, B.; Coppola, N.; Ruggiero, T.; Pollicino, T.; Polilli, E.; Pasquazzi, C.; Pace Palitti, V.; Magni, C.F.; Micheli, V.; Di Biagio, A.; Sticchi, L.; Melis, M.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e62
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗